Patents by Inventor Meenakshi Hegde

Meenakshi Hegde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDES TARGETING CD105+ CANCERS
    Publication number: 20250041341
    Abstract: Embodiments of the present disclosure include methods and compositions related to CD105-targeting polypeptides. In some aspects, disclosed are chimeric receptors engineered to bind to CD105. Cells (e.g., NK cells, T-cells) expressing CD105-targeting peptides are described. Also described are therapeutic methods using polypeptides of the disclosure.
    Type: Application
    Filed: December 20, 2022
    Publication date: February 6, 2025
    Applicant: Baylor College of Medicine
    Inventors: Sujith Joseph, Nabil M. Ahmed, Meenakshi Hegde
  • CHIMERIC ANTIGEN RECEPTOR FOR BISPECIFIC ACTIVATION AND TARGETING OF T LYMPHOCYTES
    Publication number: 20160303230
    Abstract: Embodiments of the invention include methods and compositions related to improved cells encoding a chimeric antigen receptor that is specific for two or more antigens. In certain aspects the receptor encompasses two or more non-identical antigen recognition domains. The antigens are tumor antigens, in particular embodiments.
    Type: Application
    Filed: March 22, 2016
    Publication date: October 20, 2016
    Inventors: Nabil M. Ahmed, Zakaria Grada, Meenakshi Hegde, Matthew Baker, Donald R. Shaffer